Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer

NCT02621398 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Stage II Non-Small Cell Lung Cancer
Stage IIIA Non-Small Cell Lung Cancer
Stage IIIB Non-Small Cell Lung Cancer

Interventions

RADIATION: 3-Dimensional Conformal Radiation Therapy
DRUG: Carboplatin
RADIATION: Intensity-Modulated Radiation Therapy
OTHER: Laboratory Biomarker Analysis
DRUG: Paclitaxel
BIOLOGICAL: Pembrolizumab

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]
[object Object]
[object Object]